(Q34554095)

3 August 2017

1 reference

title

Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma (English)

1 reference

3 August 2017

1 reference

1 reference

Angela Wong

1

1 reference

3 August 2017

Rebecca C Fitzgerald

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Clinical Gastroenterology and Hepatology

3 August 2017

1 reference

3 August 2017

3

1 reference

3 August 2017

1

1 reference

3 August 2017

1-10

1 reference

Continuing climb in rates of esophageal adenocarcinoma: an update

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

1 reference

7 January 2021

Time trends in oesophageal cancer incidence in Côte d'Or (France), 1976-93.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

The decline in the incidence of stomach cancer in Sweden 1960-1984: a birth cohort phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Barrett's esophagus: age, prevalence, and extent of columnar epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Barrett's esophagus in children and young adults. Frequent association with mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Characteristics and regional variations of patients with Barrett's oesophagus in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Gastroesophageal reflux among different racial groups in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Risk factors for Barrett's esophagus: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Lifestyle factors and Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Occupation and risk of esophageal and gastric cardia adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Can symptoms predict endoscopic findings in GERD?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Surveillance and survival in Barrett's adenocarcinomas: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Prevalence of Barrett's esophagus in asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Screening for Barrett's esophagus in colonoscopy patients with and without heartburn

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Association between body mass and adenocarcinoma of the esophagus and gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Body mass and reflux oesophagitis: an oestrogen-dependent association?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Potential genotoxicity of chronically elevated nitric oxide: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Novel mechanism of nitrosative stress from dietary nitrate with relevance to gastro-oesophageal junction cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Carcinogenesis at the gastroesophageal junction: free radicals at the frontier

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Selenium and its relationship to cancer: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Selenium Supplementation and Secondary Prevention of Nonmelanoma Skin Cancer in a Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Aspirin use and cancers of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Barrett's esophagus and the presence of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Helicobacter pylori infection in patients with Barrett's oesophagus: a prospective immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900602-0

7 January 2021

10.1016/S1542-3565(04)00602-0

Identifiers

DOI

1 reference

release_2k3zezlekvexnbewh6bt32fyvi

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2k3zezlekvexnbewh6bt32fyvi

24 November 2022

mapped directly with Wikidata item

1 reference